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WORSENING OF MALNUTRITION-INFLAMMATION SCORE IS ASSOCIATED
WITH HIGH RATIO OF EXTRACELLULAR TO TOTAL BODY WATER IN
HEMODIALYSIS PATIENTS
Narihito Tatsumoto, Hiroshi Tanaka, Shoji Tsuneyoshi
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima,
Japan
The Malnutrition-Inﬂammation Score (MIS) has been reported to be
associated with mortality in hemodialysis (HD) patients. Bioelectrical
impedance analysis is useful for assessing the body ﬂuid components. The
purpose of this study is to evaluate the association between change in MIS and
ﬂuid components in HD patients. A total of 76 patients who were receiving a
5-hour HD, 3 times weekly, were enrolled in this study. MIS was performed
every 6 months. Using IN BODY 720, body ﬂuid components were estimated
once a year, including intracellular water (ICW), extracellular water (ECW), total
body water (TBW), total body fat, body fat percentage and ECW/TBW ratio. In
univariate analysis, worsening of MIS was correlated positively with age and
ECW/TBW ratio. In multivariate analysis, worsening of MIS was signiﬁcantly
associated with higher ECW/TBW ratio. Higher ECW/TBW ratio remained
signiﬁcantly correlated with worsening of MIS in non-obese HD patients, but
not in obese patients. In conclusion, non-obese HD patients who has higher
ECW/TBW ratio should be considered to be a risk group for malnutrition.
http://dx.doi.org/10.1016/j.krcp.2012.04.575
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Nutritional status is an important predictor of clinical outcome in
dialysed patients. Beside decreased serum protein/albumin,lower BMI with
decreased muscle mass is the most signiﬁcant predictor of morbidity and
mortality. Keto amino acids (KA) represent an additional source for protein
anabolism inﬂuencing indirectly also carbohydrate and lipid
metabolism,Ca-P and acid base balance.Additionaly,by concominant
metabolic and hemodynamic effect on residual nefrons, KA can help to
slow progression of residual renal function (RRF) mainly in peritoneal
dialysis patients. We conducted a long-term prospective randomized
placebo controlled trial to test whether a modiﬁed low-protein diet (LPD)
with or without keto acids (KA) would be safe ,well tolerated and
associated with an increase of metabolic status and preservation of RRF in
peritoneal dialysis (PD). We evaluated a total of 62 PD patients (32M/30F)
aged 26-72 yrs with creatinine clearance (Ccr) 7.9-5.7 mL/min/1.73m2 for a
period of 12 months. All patients were on modiﬁed LPD containing
0.8 protein/kg/IBW/day and 135/kJ/kg/IBW/day. LPD was randomly
supplemented with KA at dosage of 100 mg/kg/IBW/day (30 patients,
Group I) while 30 patients (Group II) received placebo. We analysed also
muscle and fat metabolism by MR spectroscopy (MRS, m.tibialis anterior))
and imagining (MRI,visceral fat).Patients from Group I were before
enrolment on conservative management using LPD þ KA (0.6g P þ 0.1g
KA/kg/IBW/day) for longer time (18-48 months, median 28) with good
compliance (SGA). Patients from group II were never treated with LPD and
KA.All patients were monitored at the beginning of PD and at every
3 months for 12 months.;A neutral or positive long- term nitrogen balance
(nPCR in g/kg IBW/day) was achieved in Group I (po0.05 ).RRF measured
as Ccr remained stable in Group I (6.5 7 2.18 to 5.9 7 2.54 ml/min,
p¼NS),while it decreased in Group II (6.7 7 2.22 to 3.2 7 1.44 ml/min,
po0.02).There were no differences in Dialysate clearance (DCcr(L/week/
1.73 m2).At the end of the study,there were signiﬁcant differences in Total
clearance per week expressed as Dialysate clearance þ Residual creatinine
clearance (TCcr¼DCcr þ RCcr), Po 0.01 and Total Kt/Vurea/week,Po
0.01.Serum albumin increased signiﬁcantly (from 29.5 7 2,5 to 35.4 7
3.4 g/L, Po 0.01) in Group I comparing to Group II ( 30.4 7 3.4 to 31.8 7
3.5 g/L, P ¼NS).Also urine output was sigiﬁcantly higher in Group I (1226
7 449 mL/day) than in Group II ( 6787 327 mL/day, Po 0.01),
respectively).Fat in muscle measured by MR spectroscopy (MRS, m.tibialis
anterior) signiﬁcantly decreased in Group I and was linked to reduced
volume of visceral fat measured by MRI (po0.02). In conclusion,
comparing to control Group II, long-term administration of modiﬁed
LPDþKA was associated in Group I with better metabolic status and
residual renal function.(RRF ,diuresis,Total clearance,Total Kt/V (urea),,.S-
albumin and nPCR).We conﬁrmed positive changes in muscle mass and fat
metabolism measured by MRS and MRI. Long-term administration of KA
supplemented diet in dialysed patients was safe and well
tolerated.Thus,this regimen may ramarkable increase nutritional status
and clinical outcome of dialysed patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.576
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Levels of endogenous nitric oxide synthase inhibitor asymmetric
dimethylarginine (ADMA) are elevated in chronic kidney disease (CKD) and
may contribute to vascular complications. In this study we tested the
hypothesis that elevated ADMA can be reduced in CKD patients by long-term
administration of low-protein diet (LPD) supplemented with keto amino acids
(KA). In a long-term prospective double blind placebo controlled randomized
trial, we evaluated a total of 120 CKD patients (62/58F) aged 22-76 yrs with
creatinine clearance 22-40mL/min/1.73m2 for a period of 36 months. All
patients were on low-protein diet containing 0.6 protein/kg/IBW/day and 120-
125/kJ/kg/IBW/day. LPD was randomly supplemented with KA at dosage of 100
mg/kg/IBW/day (61 patients, Group I) while 59 patients (Group II) received
placebo. During the study period, glomerular ﬁltration rate (GFR) slightly
decreased (Ccr from 34.2711.6 to 29.979.2 mL/min and 33.5711.6 to
22.2710.4 mL/min in Group I and II, respectively); this however was more
marked in Group II (po0.01). Fat in muscle measured by MR spectroscopy
(MRS, m.tibialis anterior) signiﬁcantly decreased in Group I and was linked to
reduced volume of visceral fat measured by MRI (po0.01). Reduction of fat in
Group II was not signiﬁcant. In Group I, there was a signiﬁcant decrease in the
plasma level of ADMA (from 2.470.4 to 1.270.3 mmol/L, po0.01), but ADMA
remained unchanged in Group II. A further remarkable ﬁnding was reduction in
the plasma concentration of pentosidine (from 4867168 to 3257127 mg/L,
po0.01) and decrease of proteinuria (from 3.772.20 to 1.671.2 g/24hrs,
po0.01) in Group I. Plasma adiponectin (ADPN) in Group I rose (po0.01).
Analysis of lipid spectrum revealed a mild yet signiﬁcant decrease in total
cholesterol and LPD-cholesterol (po0.01), more pronounced in Group I. In
Group I, there was a decrease in plasma triglycerides (from 3.871.5 down to
2.370.5 mmol/L, po0.01), whereas glycated hemoglobin (HbAc1) decreased
from 7.071.3 to 4.170.9 %, (po0.01) nIn conclusion,comparing to placebo
group long term co-administration of LPD and KA in CKD patients led to
decrease of ADMA,fat in muscle and visceral body fat, and proteinuria.
Concomitant decreases of glycated haemoglobin, LDL-c and pentosidine may
also contribute to the delay in progression of renal failure and decrease of
cardiovascular risk factors..The study was supported by Research Project MZO
00023001 awarded by Ministry of Health of the Czech Republic
http://dx.doi.org/10.1016/j.krcp.2012.04.577
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Insulin resistance is common in dialyzed patients and is associated with
increased mortality and protein-energy wasting. The aim of this study was to
investigate the effect of pioglitazone (PIO), a powerful insulin sensitizer, on
insulin sensitivity, body composition and adipose tissue metabolism, in
dialyzed patients. A double blind randomized cross-over study was performed
in non diabetic dialysis patients. Each patient followed 2 treatment phases of
16 weeks, starting either with oral PIO 45 mg/d or placebo (PL), and then
switched to the other phase. At the end of each phase, patients underwent
hyperinsulinemic euglycemic clamps, dual energy X-ray absorptiometry, an
abdominal CT, and extensive plasma biochemical analysis. Twelve patients
including 8 HD (59.674.4 y) and 4 PD patients (43.573.6 y) were recruited.
Nine patients completed both phases and 3 patients dropped out (renal
transplantation/2 HD and peritonitis/1 PD). PIO was safe and well tolerated.
Kidney Res Clin Pract 31 (2012) A16–A96A80
